Keywords
emotional disorders
metabolic disorders
depression
How to Cite
Abstract
The psycho-emotional state has the most significant effect on the clinical picture and course of diabetes of any type. According to many researchers, it is known that patients with diabetes suffer from depression almost three times more often than patients without it. When the patient has symptoms of depression, his emotional state is disturbed, which quite often leads to the patient's refusal of the prescribed necessary treatment, and eventually decompensation of the somatic state occurs. In turn, it causes new episodes of depression, which requires the use of psychotropic drugs and psychotherapy. A comprehensive clinical-psychopathological and psychodiagnostic examination of 82 patients with type II diabetes of moderate and severe forms was conducted. The average duration of diabetes was (7.9±5.2) years. Emotional disorders are represented by anxious, depressive, astheno-hypochondriac, hysteroform variants of psychopathological symptoms. Cognitive dysfunction is a frequent complication of type II diabetes. It is associated with both the age-related aspect of the disease and the pathological dysmetabolic cascade that forms basis of the pathogenesis of diabetic encephalopathy development. Cognitive decline in type II diabetes has a mixed (vascular-degenerative) nature and is characterized by complaints of decreased working capacity, and is marked by a decrease in memory, auditory-speech and visual modalities, slowing of thinking, decreased concentration of attention, absent-mindedness, inability to focus on performance of a certain task for a long time. The analysis of cognitive functions using the MMSE method showed that the examined patients had mild or moderate cognitive impairments in the form of a decrease in verbal memory, a decrease in the speed of calculation operations, difficulty in orientation, and a decrease in indicators of the perceptual-gnostic sphere.
Keywords: cognitive disorders, emotional disorders, metabolic disorders, depression.
References
Sinaiko VM, Zemlianitsyna OV. Features of excretion of melatonin in urine in patients with type 2 diabetes mellitus and NAFLD with manifestations of fibrosis and its relationship with certain metabolic and immunological indicator. Georgian Medical News. 2018;1(274):103-7. PMID: 29461236.
Rodriguez-Manas L, Laosa O, Vellas B, Paolisso G, Topinkova E, Oliva-Moreno J. et al. Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus. Journal of Cachexia, Sarco-penia and Muscle. 2019;10(4):721-33. DOI: 10.1002/jcsm.12432.
Mankovsky B, Zherdova N, Dalhuisen I, van den Berg E, de Bresser J, Biessels GJ. Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus. Diabetic Medicine. 2018;35(12):1663-70. DOI: 10.1111/dme.13800. PMID: 30230019.
Radchenko OM, Korolyuk OYa. Osoblivosti perebigu cukrovogo diabetu pri riznih tipah zagalnih nespecifichnih adaptacijnih reakcij [Peculiarities of ischemic heart disease course and treatment in patients with glucose metabolism impairment and diabetes mellitus]. International journal of endocrinology. 2003;3:68-71. Available at: http://nbuv.gov.ua/UJRN/Mezh_2015_6_4 [in Ukrainian].
Hamasaki H. Daily physical activity and type 2 diabetes: a review. World Journal of Diabetes. 2016;7(12):243-51. DOI: 10.4239/wjd.v7.i12.243. PMID: 27350847.
Mihajlov BV. Secondary depression in pationts with cardiovascular and cerebrovascular diseases. Psychiatry, psychotherapy and clinical psychology. 2017;8(1):64-9. Available at: http://surl.li/kbdog
Chugunov VV, Markova MV, Kozhina GM, Kurilo VO, Tkachenko OV, Danilevska NV, et al. Peculiarities of the structure and distribution of weakness in the structure of type 2 diabetes mellitus among different social groups. Problems of Endocrine Pathology. 2020;2(72):89-94. DOI: 10.21856/j-PEP.2020.2.11.
Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. The Lancet Neurology. 2008;7(2):184-90. DOI: 10.1016/S1474-4422(08)70021-8. PMID: 18207116
Pashkovska NV. Kognitivni porushennya pri cukrovomu diabeti tipu 2: rol gipoglikemizuyuchoyi terapiyi [Cog-nitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy]. International journal of endocrinology. 2018;14(1):76-85. Available at: http://nbuv.gov.ua/UJRN/Mezh_2018_14_1_18
Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American diabetes association. Diabetes Care. 2016;39(11):2065-79. DOI: 10.2337/dc16-1728. PMID: 27926890.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.